Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Explorative Open Phase II-study, Food Allergy Suppression Therapy During Protection With Xolair

NCT02402231 is registered in ClinicalTrials.gov with Caroline Nilsson as lead sponsor.

NCT NCT02402231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02402231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Explorative Open Phase II-study, Food Allergy Suppression Therapy During Protection With Xolair
Lead sponsor
Caroline Nilsson
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2013
Completion date
October 31, 2020
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peanut allergy